What is the main purpose of an Investigational New Drug (IND) application?

What is the main purpose of an Investigational New Drug (IND) application?

• A. To license manufacturing facilities
• B. To grant marketing approval
• C. To request expedited approval
• D. To allow human clinical trials to begin in the United States

Answer: (D)

The main purpose of an Investigational New Drug application is to allow human clinical trials to begin in the United States. It provides FDA with preclinical safety data, information about how the drug is manufactured, and detailed plans for the proposed clinical studies, including protocols and protections for participants. Only after FDA reviews and finds the IND acceptable can a sponsor start testing the drug in people, under controlled conditions. Other options miss the central function of the IND. Licensing manufacturing facilities involves separate regulatory actions (facility registration and GMP compliance) rather than the IND itself. Marketing approval comes after successful trials, through an NDA/BLA, not from the IND. Expedited approval pathways exist but are distinct from the IND and require additional criteria and submissions.

The main purpose of an Investigational New Drug application is to allow human clinical trials to begin in the United States. It provides FDA with preclinical safety data, information about how the drug is manufactured, and detailed plans for the proposed clinical studies, including protocols and protections for participants. Only after FDA reviews and finds the IND acceptable can a sponsor start testing the drug in people, under controlled conditions.

Other options miss the central function of the IND. Licensing manufacturing facilities involves separate regulatory actions (facility registration and GMP compliance) rather than the IND itself. Marketing approval comes after successful trials, through an NDA/BLA, not from the IND. Expedited approval pathways exist but are distinct from the IND and require additional criteria and submissions.